1H MRS in Mild Cognitive Impairment: What Are We Measuring, and How Good Are We at It?

Adding MRS to ADNI Criteria for Drug Monitoring Will Reduce Group Size for Clinical Trials

Cerebral Blood Perfusion Dynamics in Alzheimer’s Disease and Mild Cognitive Impairment Using Discrete Modeling of Arterial Spin Labeling MRI

Characterize the Distribution and Behavior Significance of the Global Signal Measured by Resting-State Functional Connectivity in the Elderly

Different Stages in Alzheimer's Disease Target Different Large-Scale Networks, Assessed by Resting-State Functional Connectivity